290
Participants
Start Date
July 22, 2025
Primary Completion Date
February 28, 2026
Study Completion Date
February 28, 2026
Single dose of 1800 mg L9LS SC
A human monoclonal antibody to protect against Plasmodium falciparum.
Placebo
Normal saline
RECRUITING
Faladje MRTC Clinic, Faladié
RECRUITING
Kalifabougou MRTC Clinic, Kalifabougou
RECRUITING
Torodo MRTC Clinic, Torodo
National Institutes of Health (NIH)
NIH
Malaria Research and Training Center, Bamako, Mali
OTHER
University of the Sciences, Techniques and Technologies of Bamako
OTHER
Faculté de Médecine Pharmacie d'Odontostomatologie (FMOS)
UNKNOWN
University of Washington
OTHER
Harvard School of Public Health (HSPH)
OTHER
Indiana University School of Medicine
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH